The projection of neuronal processes is guided by a variety of soluble and insoluble factors, which are sensed by a fiber’s growth cone. It is the differential distribution of such guidance cues that determine the direction in which neurites grow. The growth cone senses these cues on a fine scale, using extensible filopodia that range from a few to tens of µm in length. In order to study the effects of guidance cues on spiral ganglion (SG) neurites, we have used methods for distributing both soluble and insoluble cues on a scale appropriate for sensing by growth filopodia. The scale of these methods are at the micro, rather than nano, level to match the sensing range of the growth cone. Microfluidics and transfected cells were used to spatially localize tropic factors within the fluid environment of extending neurites. Micropatterning was used to present neurites with stripes of insoluble factors. The results indicate that differentially distributed permissive, repulsive and stop signals can control the projection of SG neurites. Implications for future micropatterning studies, for SG development and for the growth of deafferented SG dendrites toward a cochlear implant are discussed.

Keywords:
Spiral ganglion neurite guidance, Micropatterning, Neurite growth
1.
Aletsee C, Beros A, Mullen L, Palacios C, Pak K, Dazert S, Ryan AF: Ras/MEK but not p38 signaling mediates neurite extension from spiral ganglion neurons. JARO 2001a;2:377–387.
2.
Aletsee C, Beros A, Mullen L, Palacios S, Pak K, Dazert S, Ryan AF: The disintegrin kistrin inhibits neurite extension from spiral ganglion explants cultured on laminin. Audiol Neurootol 2001b;6:57–65.
3.
Aletsee C, Brors D, Mlynski R, Ryan AF, Dazert S: Branching of spiral ganglion neurites is induced by focal application of fibroblast growth factor-1. Laryngoscope 2003;113:791–796.
4.
Aletsee C, Kim D, Dazert S, Ryan AF: Fibronectin boundaries influence the outgrowth of spiral ganglion neurons in vitro. Abstr ARO 2000;23:130.
5.
Bianchi LM, Liu H: Comparison of ephrin-A ligand and EphA receptor distribution in the developing inner ear. Anat Rec 1999;254:127–134.
6.
Brors D, Aletsee C, Schwager C, Mlynski R, Hansen S, Schafers M, Ryan AF, Dazert S: Interaction of spiral ganglion neuron processes with alloplastic materials in vitro. Hear Res 2002;167:110–121.
7.
Brors D, Bodmer D, Pak K, Aletsee C, Schafers M, Dazert S, Ryan AF: EphA4 provides repulsive signals to developing cochlear ganglion neuritis mediated through ephrin-B2 and -B3. J Comp Neurol 2003;462:90–100.
8.
Cao X, Shoichet MS: Investigating the synergistic effect of combined neurotrophic factor concentration gradients to guide axonal growth. Neuroscience 2003;122:381–389.
9.
Davis RL: Gradients of neurotrophins, ion channels, and tuning in the cochlea. Neuroscientist 2003;9:311–316.
10.
Dazert S, Kim D, Luo L, Aletsee C, Garfunkel S, Maciag T, Baird A, Ryan AF: Focal delivery of fibroblast growth factor-1 by transfected cells induces spiral ganglion neurite targeting in vitro. J Cell Physiol 1998;177:123–129.
11.
Dertinger SK, Chiu DT, Jeon NL, Whitesides GM: Generation of gradients having complex shapes using microfluidic networks. Anal Chem 2001;73:1240–1246.
12.
Dertinger SK, Jiang X, Li Z, Murthy VN, Whitesides GM: Gradients of substrate-bound laminin orient axonal specification of neurons. Proc Natl Acad Sci USA 2002;99:12542–12547.
13.
Duffy DC, McDonald JC, Schueller OJ, Whitesides GM: Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 1998;70:4974–4984.
14.
Echteler SM: Developmental segregation in the afferent projections to mammalian auditory hair cells. Proc Natl Acad Sci USA 1992;89:6324–6327.
15.
Echteler SM, Nofsinger YC: Development of ganglion cell topography in the postnatal cochlea. J Comp Neurol 2000;425:436–446.
16.
Ernfors P, Lee KF, Jaenisch R: Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994;368:147–150.
17.
Evans A, Pak K, Mullen L, Bhatia S, Ryan AF: Micropatterning of extracellular matrix molecules reveals preference by cochlear ganglion neurites, submitted.
18.
Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994;369:658–661.
19.
Fritzsch B, Barbacid M, Silos-Santiago I: The combined effects of trkB and trkC mutations on the innervation of the inner ear. Int J Dev Neurosci 1998;16:493–505.
20.
Fritzsch B, Farinas I, Reichardt LF: Lack of neurotrophin 3 causes losses of both classes of spiral ganglion neurons in the cochlea in a region-specific fashion. J Neurosci 1997a;17:6213– 6225.
21.
Fritzsch B, Silos-Santiago I, Bianchi L, Farinas I: Effects of neurotrophin and neurotrophin receptor disruption on the afferent inner ear innervation. Semin Cell Dev Biol 1997b;8:277–284.
22.
Gallo G, Letourneau PC: Regulation of growth cone actin filaments by guidance cues. J Neurobiol 2004;58:92–102.
23.
George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO: Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993;119:1079–1091.
24.
Gillespie LN: Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors. Clin Exp Pharmacol Physiol 2003;30:724–733.
25.
Hari A, Djohar B, Skutella T, Montazeri S: Neurotrophins and extracellular matrix molecules modulate sensory axon outgrowth. Int J Dev Neurosci 2004;22:113–117.
26.
Jain A, Brady-Kalnay SM, Bellamkonda RV: Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension. J Neurosci Res 2004;77:299–307.
27.
Kim D, Pak K, Aletsee C, Mullen L, Dazert S, Ryan AF: Fibronectin enhances spiral ganglion neurite outgrowth in vitro. Hear Res, submitted.
28.
Koeberle PD, Bahr M: Growth and guidance cues for regenerating axons: where have they gone? J Neurobiol 2004;59:162–180.
29.
Lefebvre P, Weber T, Rigo J, Staecker H, Moonen G, Van De Water T: Peripheral and central target-derived trophic factor(s) effects on auditory neurons. Hear Res 1992;58:185–192.
30.
Lenoir M, Shnerson A, Pujol R: Cochlear receptor development in the rat with emphasis on synaptogenesis. Anat Embryol 1980;160:253–262.
31.
Luo L, Koutnouyan H, Baird A, Ryan, AF: Expression of mRNA encoding acidic and basic FGF in the adult and developing cochlea. Hear Res 1993;69:182–193.
32.
Malgrange B, Lefebvre PP, Martin D, Staecker H, Van de Water TR, Moonen G: NT-3 has a tropic effect on process outgrowth by postnatal auditory neurones in vitro. Neuroreport 1996b;7:2495–2499.
33.
Malgrange B, Lefebvre P, Van De Water TR, Staecker H, Moonen G: Effects of neurotrophins on early auditory neurones in cell culture. Neuroreport 1996a;7:913–917.
34.
Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL: Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005;121:127–139.
35.
Nguyen-Ba-Charvet KT, Brose K, Marillat V, Sotelo C, Tessier-Lavigne M, Chedotal A: Sensory axon response to substrate-bound Slit2 is modulated by laminin and cyclic GMP. Mol Cell Neurosci 2001;17:1048–1058.
36.
Oster SF, Deiner M, Birgbauer E, Sretavan DW: Ganglion cell axon pathfinding in the retina and optic nerve. Semin Cell Dev Biol 2004;15:125–136.
37.
Pickles JO, Claxton C, Van Heumen WR: Complementary and layered expression of Ephs and ephrins in developing mouse inner ear. J Comp Neurol 2002;449:207–216.
38.
Pirvola U, Arumae U, Moshnyakov M, Palgi J, Saarma M, Ylikoski J: Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 1994;75:131–144.
39.
Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumae U, Saarma M: Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci USA 1992;89:9915– 9919.
40.
Staecker H, Kopke R, Malgrange B, Lefebvre P, Van De Water TR: NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889–894.
41.
Tessarollo L, Coppola V, Fritzsch B: NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J Neurosci 2004;10:2575–2584.
42.
Tsuprun V, Santi P: Ultrastructure and immunohistochemical identification of the extracellular matrix of the chinchilla cochlea. Hear Res 1999;129:35–49.
43.
Tsuprun V, Santi P: Proteoglycan arrays in the cochlear basement membrane. Hear Res 2001;157:65–76.
44.
Van De Water TR, Ruben RJ: Organ culture of the mammalian inner ear. Acta Otolaryngol 1971;71:303–312.
45.
van Heumen WR, Claxton C, Pickles JO: Expression of EphA4 in developing inner ears of the mouse and guinea pig. Hear Res 2000;139:42–50.
46.
Vielmetter J, Stuermer CA: Goldfish retinal axons respond to position-specific properties of tectal cell membranes in vitro. Neuron 1989;2:1331–1339.
47.
Walter J, Kern-Veits B, Huf J, Stolze B, Bonhoeffer F: Recognition of position-specific properties of tectal cell membranes by retinal axons in vitro. Development 1987;101:685–696.
48.
Weinl C, Drescher U, Lang S, Bonhoeffer F, Loschinger J: On the turning of Xenopus retinal axons induced by ephrin-A5. Development 2003;130:1635–1643.
49.
Whitlon D, Zhang X, Pecelunas K, Greiner M: A temporospatial map of adhesive molecules in the organ of Corti of the mouse cochlea. J Neurocytol 1999;28:955–968.
50.
Wittig J, Ryan AF, Asbeck P: A reusable microfluidic plate with alternate-choice architecture for assessing growth preference in tissue culture. J Neurosci Meth 2005;144:79–89.
51.
Woolf N, Koehrn FJ, Ryan AF: Expression of fibronectin in the developing inner ear of the gerbil and rat. Dev Brain Res 1992;65:21–33.
52.
Yamamoto N, Tamada A, Murakami F: Wiring of the brain by a range of guidance cues. Prog Neurobiol 2002;68:393–407.
53.
Yoshikawa S, Thomas JB: Secreted cell signaling molecules in axon guidance. Curr Opin Neurobiol 2004;14:45–50.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.